December 17, 2014 07:00 ET

LifeLabs Medical Laboratory Services Announces Two Executive Appointments

Attention Business & Healthcare Editors

TORONTO, ONTARIO and VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 17, 2014) - LifeLabs Medical Laboratory Services is pleased to announce the appointment of two senior executives. On November 3rd, Mr. Brian Forster joined LifeLabs as the Senior Vice President of Information Technology & Chief Information Officer. On December 15th, Dr. Ronald Carter joined LifeLabs as the Director, Molecular Genetics Laboratory.

Mr. Forster has extensive experience developing and executing business and information technology strategies in the health care, financial services, education and energy industries. Most recently, he was CEO at OntarioMD where he led the delivery of Ontario's EMR Adoption program involving over 11,000 Ontario community physicians.

As Senior Vice President of Information Technology & CIO Mr. Forster will lead LifeLabs' continued innovation and excellence in lab sector technology and will broaden LifeLabs' e-health strategy. In addition to being a member of LifeLabs' Executive Leadership Team, Mr. Forster will join the Board of Directors of Excelleris, LifeLabs' technology subsidiary.

"LifeLabs is privileged to have someone of Brian's stature and experience joining us at this exciting time in our evolution as Canada's leading community laboratory, and as an emerging leader in health information for providers and patients," said Sue Paish, President and CEO of LifeLabs.

Dr. Carter will lead the LifeLabs' genetics team and oversee LifeLabs' new genetics laboratory opening in Toronto in January 2015. Dr. Carter will play a pivotal role in LifeLabs' drive to be Canada's leader in genetic testing. Dr. Carter will work with academic, industry and public partners to transform emergent technologies into meaningful genetic services that will inform diagnosis, prognosis and treatment.

"LifeLabs is truly fortunate to have Ron join our organization," said Jeff Sumner, LifeLabs' Senior Vice President of Business Development, Clinical Affairs and Genetics. "His addition to our team will strengthen LifeLabs' position as a leading provider of high quality, accessible and innovative diagnostic testing services in Canada."

Dr. Carter has extensive experience in diagnostic genetics, most recently as Director of Laboratory Genetic Services and Head of Cancer Genetics for the Hamilton Regional Laboratory Medicine Program. He has specialty certifications in both molecular genetics and cytogenetics. He has provided consulting support to multiple hospitals and served on numerous provincial and federal advisory committees, and has been active in training undergraduate medical students as well as postdoctoral fellows and medical residents at McMaster University.

About LifeLabs:

LifeLabs is a Canadian-owned company with over 50 years of experience providing laboratory testing services to help health care providers diagnose, treat, monitor and prevent disease. In communities across British Columbia and Ontario, LifeLabs provides cost-effective, convenient access to laboratory testing services which are essential for optimal outcomes in health care. LifeLabs employs approximately 5,400 professionally trained staff and delivers over 100 million laboratory tests, serving 19 million patient visits annually. In 2013, LifeLabs acquired BC Biomedical in British Columbia and CML HealthCare in Ontario making LifeLabs the largest community laboratory in Canada. LifeLabs is indirectly owned by OMERS Administration Corporation, whose interest is managed by Borealis Infrastructure.

About Borealis Infrastructure:

Borealis Infrastructure is a leader in direct infrastructure investing with over a decade of investment experience. Borealis manages more than $11 billion in OMERS equity capital through investments in a diversified portfolio of large-scale infrastructure assets exhibiting stability and strong cash flows, in sectors including energy, transportation and social infrastructure. It has offices in Toronto, London, New York and Sydney. Borealis is the infrastructure investment arm of OMERS, one of Canada's largest pension funds with net assets of more than $65 billion and an AAA credit rating. For more information please visit or

Contact Information